Ovarian cancer is the deadliest gynecological malignancy affecting American women, and obesity and diabetes are associated with a worse prognosis due in part to the effects of elevated levels of insulin and IGF on cancer cells [17,18]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.